Last reviewed · How we verify
Staphylococcus Chronic Bronchitis
Approved treatments
- Avelox · Bayer AG
Fourth-generation fluoroquinolone with the broadest spectrum, covering gram-positive, gram-negative, anaerobic, and atypical organisms. - Avelox · Novartis Pharmaceuticals
- Zymar · Allergan
- Noroxin
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Staphylococcus Chronic Bronchitis patent landscape — cliff calendar, originator estates, attackable patents
- Staphylococcus Chronic Bronchitis treatment landscape brief
- Staphylococcus Chronic Bronchitis treatment updates RSS
Frequently asked questions about Staphylococcus Chronic Bronchitis
What drugs treat Staphylococcus Chronic Bronchitis?
Tracked treatments include Avelox, Zymar, Noroxin.
What is the treatment for Staphylococcus Chronic Bronchitis?
Standard treatment for Staphylococcus Chronic Bronchitis includes Avelox, Zymar, Noroxin. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Staphylococcus Chronic Bronchitis patent cliff · Staphylococcus Chronic Bronchitis CI report
- Treatment: Avelox · Bayer AG
- Treatment: Avelox · Novartis Pharmaceuticals
- Treatment: Zymar · Allergan
- Treatment: Noroxin
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing